Outlook Therapeutics, Inc. · NASDAQ:OTLK

GMS VENTURES & INVESTMENTS reported a 38.60% stake in Outlook Therapeutics, Inc. (Schedule 13D/A)

Event Jan 17, 2025 · Filed Jan 22, 2025

GMS VENTURES & INVESTMENTS reported a 38.60% stake in Outlook Therapeutics, Inc., 12,725,216 shares, with active intent on Jan 17, 2025. Filed Jan 22, 2025 (Schedule 13D/A).

Stake
38.60%
Shares
12,725,216
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
GMS VENTURES & INVESTMENTS38.60%12,725,216
SUKHTIAN GHIATH M.38.60%12,725,216

Source

View original at SEC

Related